Gamma knife surgery is a type of radiation treatment performed with the Gamma knife, a non-invasive neurosurgical tool. Gamma knife surgery delivers small, highly precise doses of radiation into the brain. This gamma knife treatment shrinks small brain tumors or blocks abnormal blood vessels and nerves that cause pain or seizures. Gamma knife surgery can also treat some brain disorders such as Parkinson’s disease. Gamma knife surgery is an effective alternative to neurosurgery for some patients. Gamma knife surgery can help, if a person cannot tolerate neurosurgery because of medical condition, age, or preference. It is less invasive and requires less hospitalization and recovery time than neurosurgery. Gamma Knife radiosurgery is most commonly used to treat brain tumor, arteriovenous malformation (AVM), trigeminal neuralgia, and acoustic neuroma. Some of the side effects that are observed after gamma knife treatment include fatigue, swelling in the brain near the treated area, and scalp and hair problems.
Gamma Knife Market – Impact of Coronavirus (COVID-19) Pandemic
Lockdown in various countries has halted all the transportation facilities across the countries. This led to cancellation of various appointments for the treatment of cancer. Due to these, demand for treatment of cancer increased. Thus, this pandemic has negatively hampered global gamma knife market. The government recommended certain guidelines for safety measures during the gamma knife procedures for the staff and the patients –
The global gamma knife market is estimated to be valued at US$ 215.8 million in 2020 and is expected to exhibit a CAGR of 4.5% during the forecast period (2020-2027).
Figure 1. :Global Gamma Knife Market Share (%) Regional Analysis, 2027
Increasing product launches and prevalence of gamma knife treatment are expected to drive growth of the global gamma knife market
Major factors assisting the market growth during the forecast period include rising launch of products and approvals from regulatory bodies. For instance, in March 2018, Sunway Medical Centre (SunMed), Malaysia’s multi-disciplinary Medical Centre, introduced Leksell Gamma Knife Icon (an advanced radiation machine, which was manufactured by Elekta AB). It is used for the treatment of various neurological disorders and brain conditions such as Pituitary tumors that require open brain surgery.
Furthermore, increasing prevalence of trigeminal neuralgia is expected to drive growth of the global gamma knife market. For instance, according to the American Academy of Family Physicians 2016 article, the annual incidence of trigeminal neuralgia is 5.9/100,000 women and 3.4/100,000 men in the U.S.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2019 | Market Size in 2020: | US$ 215.8 Mn |
| Historical Data for: | 2017 to 2019 | Forecast Period: | 2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: | 4.5% | 2027 Value Projection: | US$ 294.5 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Elekta AB, American Radiosurgery Inc., and Masep Medical Science & Technology Development Co., Ltd. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Gamma Knife Market – Restraints
Growth of the global gamma knife market is expected to be hampered over the forecast period, owing to increasing FDA recalls. For instance, in June 2018, the U.S. Food and Drug Administration recalled the Leksell GammaPlan 11.1, it was a treatment planning and management software, under Class 2 Device Recall due to the gamma knife system that overestimated the treatment duration and planning margin. This system was recalled from many countries such as Australia, Belgium, France, Germany, Hong Kong, Italy, Japan, Korea, Democratic People's Republic of Korea, Netherlands, Romania, Russian Federation, Spain, Turkey, and the U.K. in May 2019.
Gamma Knife Market – Regional Analysis
On the basis of region, the global gamma knife market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to be the most profitable region in the gamma knife market during the forecast period, attributed to increasing approval and launches of gamma knife systems in this region, which is further expected to drive the market growth in North America. For instance in 2017, Elekta’s Leksell Gamma Knife Icon radiosurgery system received medical device license from Health Canada. The gamma knife radiosurgery system is the most recent advanced radiosurgery system for treatment of head- and neck-related disorders such as brain metastases, facial nerve pain. This clearance in turn, is expected to enable installation of this system by several healthcare providers in Canada for patients in the country to gain access to treatment with modern stereotactic radiosurgery (SRS) system.
Moreover, Asia Pacific gamma knife market is expected to witness significant growth due to increasing approval of gamma knife treatment systems during the forecast period. For instance, in 2018, Elekta's Leksell Gamma Knife Icon radiosurgery system received the clearance from China Food and Drug Administration (CFDA), enabling healthcare providers in the country to offer this advanced technology to patients in China.
Figure 2. :Global Gamma Knife Market Value (US$ Mn) & Y-o-Y Growth (%), 2016-2027
Global Gamma Knife Market - Competitive Landscape
Key players operating in the global gamma knife market include Elekta AB, American Radiosurgery Inc., and Masep Medical Science & Technology Development Co., Ltd.
Gamma knife radiosurgery is a radiation type of therapy used to treat tumors, vascular malformations, and other abnormalities in the brain. Gamma knife radiosurgery is different from other forms of stereotactic radiosurgery (SRS), as in gamma knife surgery there is no incision. Moreover, gamma knife radiosurgery uses specialized equipment to focus about 200 tiny beams of radiation on a tumor or other target with submillimeter accuracy. A strong dose of radiation is delivered to the place where all the beams meet, as compared to effect of each beam. The precision of brain stereotactic radiosurgery results in minimal radiation delivery to healthy tissues surrounding the target. This type of radiation treatment is usually performed, if a person is suffering from a tumor or other abnormality in the brain that is difficult to reach with standard neurosurgery, or a person is not healthy enough to undergo standard surgery, and if a person prefers a less invasive treatment.
Market Dynamics
Increasing collaboration between major players is expected to drive the global gamma knife market. For instance, in March 2020, Elekta and San Jose Moscati Hospital teamed up to equip new center in Queretaro State with comprehensive range of radiotherapy solutions, to treat cancer patients in Mexico. The agreement comprises a broad array of cancer treatment and radiotherapy support systems such as Elekta Unity, Leksell Gamma Knife, and brachytherapy using Flexitron, Versa HD linear accelerator, and MOSAIQ oncology information system.
However, growth of the global gamma knife market is expected to be hampered over the forecast period, owing to increasing FDA recalls. For instance, in May 2017, the U.S. Food and Drug Administration recalled the Leksell Gamma Knife Icon developed by Elekta, Inc., under Class 2 Device Recall due to safety issues.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients